Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 23 studies | 30% ± 17% | |
endothelial cell of lymphatic vessel | 12 studies | 31% ± 7% | |
pericyte | 12 studies | 30% ± 9% | |
endothelial cell | 9 studies | 32% ± 12% | |
connective tissue cell | 5 studies | 20% ± 4% | |
smooth muscle cell | 5 studies | 29% ± 8% |
Insufficient scRNA-seq data for expression of GGT5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 4527.60 | 243 / 245 | 98% | 18.57 | 493 / 502 |
thymus | 100% | 9950.50 | 653 / 653 | 97% | 53.33 | 587 / 605 |
breast | 100% | 8216.24 | 459 / 459 | 95% | 26.16 | 1059 / 1118 |
lung | 86% | 3093.73 | 499 / 578 | 93% | 21.37 | 1072 / 1155 |
adrenal gland | 99% | 4590.28 | 256 / 258 | 79% | 18.69 | 182 / 230 |
bladder | 100% | 3925.48 | 21 / 21 | 75% | 14.34 | 377 / 504 |
stomach | 87% | 2649.51 | 312 / 359 | 80% | 17.63 | 230 / 286 |
kidney | 93% | 5849.45 | 83 / 89 | 73% | 17.11 | 660 / 901 |
intestine | 86% | 2374.98 | 827 / 966 | 78% | 14.84 | 409 / 527 |
skin | 92% | 4321.30 | 1661 / 1809 | 71% | 10.85 | 337 / 472 |
uterus | 99% | 4736.97 | 168 / 170 | 63% | 9.24 | 287 / 459 |
esophagus | 84% | 2384.18 | 1207 / 1445 | 76% | 11.19 | 139 / 183 |
pancreas | 55% | 917.10 | 179 / 328 | 96% | 54.32 | 171 / 178 |
brain | 51% | 975.78 | 1337 / 2642 | 99% | 25.18 | 701 / 705 |
liver | 89% | 2221.17 | 201 / 226 | 60% | 12.59 | 245 / 406 |
ovary | 63% | 1904.37 | 114 / 180 | 53% | 6.26 | 230 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.96 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.17 | 1 / 1 |
adipose | 100% | 10106.08 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 6880.26 | 1319 / 1335 | 0% | 0 | 0 / 0 |
spleen | 96% | 2974.95 | 232 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 4280.97 | 827 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 15.05 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 57% | 7.18 | 46 / 80 |
muscle | 49% | 830.74 | 390 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 4.16 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006954 | Biological process | inflammatory response |
GO_0006750 | Biological process | glutathione biosynthetic process |
GO_0006508 | Biological process | proteolysis |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0006520 | Biological process | amino acid metabolic process |
GO_0006751 | Biological process | glutathione catabolic process |
GO_1901750 | Biological process | leukotriene D4 biosynthetic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0002951 | Molecular function | leukotriene-C(4) hydrolase |
GO_0103068 | Molecular function | leukotriene C4 gamma-glutamyl transferase activity |
GO_0000048 | Molecular function | peptidyltransferase activity |
GO_0036374 | Molecular function | glutathione hydrolase activity |
Gene name | GGT5 |
Protein name | Gamma-glutamyltransferase 5 Glutathione hydrolase 5 proenzyme (EC 3.4.19.13) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase 5) (GGT 5) (EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain] |
Synonyms | GGTLA1 |
Description | FUNCTION: Cleaves the gamma-glutamyl peptide bond of glutathione and glutathione-S-conjugate such as leukotriene C4 . Does not cleaves gamma-glutamyl compounds such as gamma-glutamyl leucine . May also catalyze a transpeptidation reaction in addition to the hydrolysis reaction, transferring the gamma-glutamyl moiety to an acceptor amino acid to form a new gamma-glutamyl compound . Acts as a negative regulator of geranylgeranyl glutathione bioactivity by cleaving off its gamma-glutamyl group, playing a role in adaptive immune responses . . |
Accessions | ENST00000398292.3 [P36269-3] H7C1X2 ENST00000425408.5 P36269 ENST00000327365.10 [P36269-1] ENST00000424217.1 ENST00000263112.11 [P36269-2] C9JU68 |